TY - JOUR
T1 - Optimization of care for patients with hereditary angioedema living in rural areas
AU - Riedl, Marc A.
AU - Johnston, Douglas T.
AU - Anderson, John
AU - Meadows, J. Allen
AU - Soteres, Daniel
AU - LeBlanc, Stephen B.
AU - Wedner, H. James
AU - Lang, David M.
N1 - Funding Information:
The authors thankyt Latoya M. Mitchell, PhD, CMPP, of Excel Medical Affairs, for providing writing assistance for this manuscript under the direction of the authors. Editorial assistance in formatting, proofreading, and copyediting was provided by Excel Medical Affairs. Disclosures: Dr Riedl reports receiving research grants from BioCryst, CSL Behring, Ionis, Kalvista, Pharvaris, and Takeda; consulting fees from BioCryst, Biomarin, CSL Behring, Cycle Pharma, Fresenius Kabi, Ionis, KalVista, Pfizer, Pharming, Pharvaris, Regenxbio, Spark, and Takeda; payments for lectures from CSL Behring, Grifols, Pharming, and Takeda; and is an advisory board member of the US Hereditary Angioedema Association. Dr Johnston reports receiving consulting/speaker fees from CSL Behring, Pharming, and Takeda; and consulting fees from BioCryst, Fresenius Kabi, and Regenxbio. Dr Anderson is a speaker bureau member for CSL Behring, Pharming, and Takeda; has received consultancy fees from CSL Behring, Pharming, and Takeda; and is a clinical trial investigator for BioCryst, CSL Behring, and Takeda. Dr Meadows reports receiving advisory board fees from Takeda. Dr Soteres reports receiving consulting/speaker/advisory board fees from BioCryst, CSL Behring, Pharming, and Takeda. Dr LeBlanc reports receiving advisory board fees from BioCryst, Ruconest, and Takeda. Dr Lang reports receiving honoraria from, has carried out clinical research with, and/or has served as a consultant for the National Institute of Allergy and Infectious Diseases, WebMD, AstraZeneca, and Genentech. Dr Wedner has no conflicts of interest to report. Funding: Takeda Development Center Americas, Inc provided funding to Excel Medical Affairs for support in writing and editing this manuscript.
Publisher Copyright:
© 2021 The Authors
PY - 2022/5
Y1 - 2022/5
N2 - Background: People living in rural areas of the United States experience greater health inequality than individuals residing in urban or suburban locations and encounter several barriers to obtaining optimal health care. Health disparities are compounded for patients with rare diseases such as hereditary angioedema (HAE), an autosomal dominant genetic disorder characterized by recurrent, severe abdominal pain and life-threatening oropharyngeal or laryngeal swelling. Objective: To explore the challenges of managing patients with HAE in rural areas and suggest possible improvements for optimizing care. Data Sources: PubMed was searched for articles on patient care management, treatment challenges, rural health, and HAE. Study Selections: Relevant articles were selected and reviewed. Results: Challenges in managing HAE in the rural setting were identified, including obtaining a diagnosis of HAE, easy access to a physician with expertise in HAE, continuity of care, availability of telemedicine services, access to approved HAE therapies, patient education, and economic barriers to treatment. Ways to improve HAE patient care in rural areas include health care provider recognition of the patient with undiagnosed HAE, development of individualized management plans, expansion of telemedicine, effective care at the local level, appropriate access to HAE medication, and increased awareness of patient support and advocacy groups. Conclusion: For patients with HAE living in rural areas, optimal care is complicated by health disparities. Given the scarcity with which these topics have been covered in the literature to date, it is intended that this article will serve as the impetus for a range of further initiatives focused on improving access to care.
AB - Background: People living in rural areas of the United States experience greater health inequality than individuals residing in urban or suburban locations and encounter several barriers to obtaining optimal health care. Health disparities are compounded for patients with rare diseases such as hereditary angioedema (HAE), an autosomal dominant genetic disorder characterized by recurrent, severe abdominal pain and life-threatening oropharyngeal or laryngeal swelling. Objective: To explore the challenges of managing patients with HAE in rural areas and suggest possible improvements for optimizing care. Data Sources: PubMed was searched for articles on patient care management, treatment challenges, rural health, and HAE. Study Selections: Relevant articles were selected and reviewed. Results: Challenges in managing HAE in the rural setting were identified, including obtaining a diagnosis of HAE, easy access to a physician with expertise in HAE, continuity of care, availability of telemedicine services, access to approved HAE therapies, patient education, and economic barriers to treatment. Ways to improve HAE patient care in rural areas include health care provider recognition of the patient with undiagnosed HAE, development of individualized management plans, expansion of telemedicine, effective care at the local level, appropriate access to HAE medication, and increased awareness of patient support and advocacy groups. Conclusion: For patients with HAE living in rural areas, optimal care is complicated by health disparities. Given the scarcity with which these topics have been covered in the literature to date, it is intended that this article will serve as the impetus for a range of further initiatives focused on improving access to care.
UR - http://www.scopus.com/inward/record.url?scp=85129781316&partnerID=8YFLogxK
U2 - 10.1016/j.anai.2021.09.026
DO - 10.1016/j.anai.2021.09.026
M3 - Review article
C2 - 34628006
AN - SCOPUS:85129781316
SN - 1081-1206
VL - 128
SP - 526
EP - 533
JO - Annals of Allergy, Asthma and Immunology
JF - Annals of Allergy, Asthma and Immunology
IS - 5
ER -